Phase 1 Malignant Brain Tumor Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients
Malignant GliomaMalignant Brain TumorEmbryonal Tumor
Assistance Publique - Hôpitaux de Paris24 enrolled3 locationsNCT05293197
Recruiting
Phase 1Phase 2
A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors
Malignant Brain Tumors
China Medical University Hospital10 enrolled2 locationsNCT07003139
Recruiting
Phase 1
Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation
Malignant Brain Tumors
Haisco Pharmaceutical Group Co., Ltd.159 enrolled6 locationsNCT07158710